Zevra Therapeutics, Inc. beat EPS estimates 100% of the time across 2 reported quarters (2 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $0.08 | — | — | Miss |
| Q12026 FY2026 | $0.06 | $0.18 | +200.0% | Beat |
| Q42025 FY2025 | $0.04 | $1.16 | +2800.0% | Beat |
Back to ZVRA overview · ZVRA holders · ZVRA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.